Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1/2 11Phase 1 11Phase 3 7Phase 2/3 3Phase EARLY_PHASE1 2

Status

Recruiting 5Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2NIH 1

Study Type

Interventional 7

Sponsor

Cancer Type

CNS 5Sarcoma 1Dermatologic 1

Conditions

Glioblastoma 4Neuroblastoma 1Neoplasms 1Melanoma, Cutaneous Malignant 1Gliosarcoma 1Glioma 1Ganglioneuroblastoma 1Brain Neoplasms 1Advanced Malignancies 1

Interventions

pembrolizumab 66Carboplatin 65Paclitaxel 54Magnetic Resonance Spectroscopy 45Cisplatin 45Specimen Handling 43Gemcitabine 36Docetaxel 31Bevacizumab 31Leucovorin 29Doxorubicin 29Dexamethasone 28Fluorouracil 27Pemetrexed 26Cyclophosphamide 26Oxaliplatin 24Radiation 23durvalumab 22Radiotherapy 22Letrozole 22Etoposide 22Nivolumab 21Irinotecan 21Vincristine 20Rituximab 20Capecitabine 20Taxes 19Prednisone 19Lenalidomide 19130-nm albumin-bound paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Temozolomide × 30 days × Clear all
NCT05902169 2026-06-05

SONOBIRD

CarThera

Phase 3 Recruiting
560 enrolled
CNS

Glioblastoma

NCT04164199 2026-06-03

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

BeOne Medicines

Phase 3 Completed
404 enrolled

Advanced Malignancies

NCT06172296 2026-06-03

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Recruiting
478 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

NCT05271240 2026-06-01

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Northwell Health

Phase 3 Recruiting
432 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT06743126 2026-05-29

SUPRAME

Immatics US, Inc.

Phase 3 Recruiting
360 enrolled
Dermatologic

Melanoma, Cutaneous Malignant

NCT07195591 2026-05-29

BRIDGES

GT Medical Technologies, Inc.

Phase 3 Recruiting
766 enrolled
CNS

Glioblastoma, Neoplasms

NCT05095376 2026-05-19

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

NRG Oncology

Phase 3 Active not recruiting
265 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡